{"database": "lobbying", "table": "lobbying_activities", "rows": [[1414893, "5355ee21-2ad5-40e6-8146-50862a17b1b4", "Q2", "ARENTFOX SCHIFF LLP", 4208, "SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING", 2013, "second_quarter", "PHA", "Pharmacy compounding of medications\nS. 959 (Pharmaceutical Quality, Security, and Accountability Act), entire bill", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2013-07-18T18:07:54.410000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1414893"], "units": {}, "query_ms": 0.39531500078737736, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}